Detalhe da pesquisa
1.
CBP/P300 BRD Inhibition Reduces Neutrophil Accumulation and Activates Antitumor Immunity in TNBC.
bioRxiv
; 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712292
2.
Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer.
bioRxiv
; 2023 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37808840
3.
Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer.
J Clin Invest
; 133(24)2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37874652